Adamas to Present at Upcoming William Blair Biotech Focus Conference

July 8, 2021 20:02 UTC

EMERYVILLE, Calif.--(BUSINESS WIRE)-- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, Chief Executive Officer, will participate in a fireside chat at the William Blair Biotech Focus Conference 2021 on Thursday, July 15, 2021 at 1:00 pm Eastern Time.

The fireside chat will be broadcast live from the investor relations section of the Adamas website at Replays of the event will be available for 30 days.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit

View source version on


Sarah Mathieson
Vice President, Corporate Communications

Peter Vozzo
Managing Director

Source: Adamas Pharmaceuticals, Inc.

Back to news